These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 627685
1. Bromocriptine: effect on serum prolactin and growth hormone in psychogeriatric hospital patients. Hontela S, Nair NP, Rosenberg G, Schwartz G, Guyda H. J Am Geriatr Soc; 1978 Feb; 26(2):49-52. PubMed ID: 627685 [Abstract] [Full Text] [Related]
2. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea. Chalmers RJ, Johnson RH, Keogh HJ, Nanda RN. J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678 [Abstract] [Full Text] [Related]
3. Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism. Felt V, Nedvdková J. Horm Metab Res; 1977 Jul; 9(4):274-7. PubMed ID: 408253 [Abstract] [Full Text] [Related]
4. Effect of a somatostatin analogue on trophic hormone levels in acromegalic patients with elevated hGH after adenomectomy and treatment with bromocriptine. Szilágyi G, Irsy G, Góth M, Szabolcs I, Coy DH, Comaru-Schally AM, Schally AV. Exp Clin Endocrinol; 1984 Oct; 84(2):190-6. PubMed ID: 6543182 [Abstract] [Full Text] [Related]
5. Neuroendocrine studies in dementia patients: responses of plasma GH and PRL following bromocriptine administration. Higashi S, Fujita M, Nishimoto Y, Kuroda K, Asaba H, Sakai T. Acta Neurol Scand; 1994 Jul; 90(1):39-44. PubMed ID: 7941955 [Abstract] [Full Text] [Related]
6. The effects of prolonged bromocriptine administration on PRL secretion GH and glycaemic control in stable insulin-dependent diabetes mellitus. Scobie IN, Kesson CM, Ratcliffe JG, Maccuish AC. Clin Endocrinol (Oxf); 1983 Feb; 18(2):179-85. PubMed ID: 6342861 [Abstract] [Full Text] [Related]
7. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women. Vermesh M, Fossum GT, Kletzky OA. Obstet Gynecol; 1988 Nov; 72(5):693-8. PubMed ID: 3173919 [Abstract] [Full Text] [Related]
9. Characterization of ergot and non-ergot serotonin antagonists by prolactin and growth hormone profiles during wakefulness and sleep. Clarenbach P, Del Pozo E, Brownell J, Heredia E, Spiegel R, Cramer H. Brain Res; 1980 Dec 08; 202(2):357-63. PubMed ID: 7437907 [Abstract] [Full Text] [Related]
10. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment. Takahashi K, Minato K, Ikeno N, Watanabe M, Endo H, Yamamoto H. Am J Obstet Gynecol; 1983 May 01; 146(1):74-9. PubMed ID: 6405619 [Abstract] [Full Text] [Related]
11. A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice. Sinha YN, Salocks CB, VanderLaan WP. Horm Metab Res; 1976 Sep 01; 8(5):332-6. PubMed ID: 989755 [Abstract] [Full Text] [Related]
12. Gel filtration studies of serum growth hormone in acromegaly following bromocriptine administration. Benker G, Sandmann K, Tharandt L, Hackenberg K, Reinwein D. Horm Res; 1979 Sep 01; 11(3):151-60. PubMed ID: 488905 [Abstract] [Full Text] [Related]
13. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins. Dawood MY, Jarrett JC, Choe JK. Fertil Steril; 1982 Oct 01; 38(4):415-8. PubMed ID: 6811337 [Abstract] [Full Text] [Related]
14. Circadian rhythmicity of prolactin secretion in elderly subjects: changes during bromocriptine treatment. Polleri A, Masturzo P, Murialdo G, Agnoli A. J Endocrinol Invest; 1981 Oct 01; 4(3):317-21. PubMed ID: 7320436 [Abstract] [Full Text] [Related]
15. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea. Caraceni T, Panerai AE, Paratl EA, Cocchi D, Müller EE. J Clin Endocrinol Metab; 1977 May 01; 44(5):870-5. PubMed ID: 140180 [Abstract] [Full Text] [Related]
16. [Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism]. Campino C, Pumarino H, Michelsen H, Piraino P, Generini G, Bruggendieck B. Rev Med Chil; 1985 Apr 01; 113(4):296-300. PubMed ID: 3915142 [No Abstract] [Full Text] [Related]
17. Nasal spray vs oral administration of bromocriptine: pharmacology and effect on serum prolactin in puerperal women. Cicinelli E, Cignarelli M, Petruzzi D, Matteo MG, Ruccia C, Schonauer LM. J Endocrinol Invest; 1996 Apr 01; 19(7):427-32. PubMed ID: 8884536 [Abstract] [Full Text] [Related]
18. Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine. Ciccarelli E, Touzel R, Besser M, Grossman A. Fertil Steril; 1988 Apr 01; 49(4):589-94. PubMed ID: 3127243 [Abstract] [Full Text] [Related]
19. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ. J Clin Endocrinol Metab; 1985 Jun 01; 60(6):1148-53. PubMed ID: 3923021 [Abstract] [Full Text] [Related]